Impact of COVID -19 on Healthy Life of People in India

Authors

  • Aishwarya Awasthi King George's Medical University, Lucknow, Uttar Pradesh
  • Shivendra Kumar Singh King George's Medical University, Lucknow, Uttar Pradesh

DOI:

https://doi.org/10.47203/IJCH.2023.v35i04.018

Keywords:

COVID, Populations, Vaccine, Lockdown

Abstract

The COVID-19 pandemic is not the first, and certainly not the last, to strike the world. COVID-19 has conjointly been a serious concern in higher-income countries, with several European countries and over eleven million individuals in the Republic of India had been infected with COVID-19. Though some countries and regions are seeing improvements in hospitalization and death rates, COVID-19 remains a significant concern for vulnerable and underserved populations globally. The COVID-19 pandemic is unexampled and heavy, and numerous of the policy measures taken to mitigate and contain it were necessary and comprehensible. Factors associated with difficulty in accessing medicine due to the COVID-19 situation With the diversion of human resources to COVID-19 work, active case finding for TB has been postponed by a number of states in India. Though regulative authorities in many countries have approved one or a lot of COVID-19 vaccines for emergency use, necessary challenges remain in mass manufacturing and distributing vaccines in developing countries. The national authorities need to arrange for the challenges associated with the health of their population coincidental with combating the COVID-19 pandemic. It's unclear, however, whether the twin impacts of COVID-19 and also the health care disruptions have an effect on these people within the semi-permanent.

Downloads

Download data is not yet available.

References

Coronavirus disease 2019 (COVID-19) Situation Report - 33.pdf. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200222-sitrep-33-363 (Accessed 25 Dec 2023).

Thienemann F, Ntusi NAB, Battegay E, Mueller BU, Cheetham M. Multimorbidity and cardiovascular disease: a perspective on low- and middle-income countries. Cardiovasc Diagn Ther. 2020;10(2):376–85.

Hamer M, Kivimäki M, Gale CR, Batty GD. Lifestyle Risk Factors for Cardiovascular Disease in Relation to COVID-19 Hospitalization: A Community-Based Cohort Study of 387,109 Adults in UK. medRxiv [Preprint]. 2020;2020.05.09.20096438.

The impact of the COVID-19 pandemic on noncommunicable disease resources and services: results of a rapid assessment. Geneva: World Health Organization; 2020. https://www.who.int/publications/i/item/ncds-covid-rapid-assessment. (Accessed on 25 Dec 2023).

Chudasama YV, Gillies CL, Zaccardi F, Coles B, Davies MJ, Seidu S, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020;14(5):965–7.

Abbas J. The impact of coronavirus (SARS-CoV2) epidemic on individuals mental health: the protective measures of Pakistan in managing and sustaining transmissible disease. Psychiatr Danub. 2020;32(3–4):472–7.

NeJhaddadgar N, Ziapour A, Zakkipour G, Abbas J, Abolfathi M, Shabani M. Effectiveness of telephone-based screening and triage during COVID-19 outbreak in the promoted primary healthcare system: a case study in Ardabil province, Iran. Z Gesundh Wiss. 2020:1–6.

Addis SG, Nega AD, Miretu DG. Psychological impact of COVID-19 pandemic on chronic disease patients in Dessie town government and private hospitals, Northeast Ethiopia. Diabetes Metab Syndr. 2021;15(1):129–35.

Yoosefi Lebni J, Abbas J, Moradi F, Salahshoor MR, Chaboksavar F, Irandoost SF, Nezhaddadgar N, Ziapour A. How the COVID-19 pandemic effected economic, social, political, and cultural factors: A lesson from Iran. Int J Soc Psychiatry. 2021;67(3):298-300

cite

Islam N, Lacey B, Shabnam S, Erzurumluoglu AM, Dambha-Miller H, Chowell G, Kawachi I, Marmot M. Social inequality and the syndemic of chronic disease and COVID-19: county-level analysis in the USA. J Epidemiol Community Health. 2021 Jan 5:jech-2020-215626

Yadav UN, Rayamajhee B, Mistry SK, Parsekar SS, Mishra SK. A syndemic perspective on the management of non-communicable diseases amid the COVID-19 pandemic in low- and middle-income countries. Front Public Health. 2020;8:508.

India State-Level Disease Burden Initiative C. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the global burden of disease study. Lancet. 2017;390(10111):2437–60.

Prabhakaran D, Jeemon P, Ghosh S, Shivashankar R, Ajay VS, Kondal D, et al. Prevalence and incidence of hypertension: results from a representative cohort of over 16,000 adults in three cities of South Asia. Indian Heart J. 2017;69(4):434–41.

Debnath R, Bardhan R. India nudges to contain COVID-19 pandemic: a reactive public policy analysis using machine-learning based topic modelling. PLoS One. 2020;15(9):e0238972.

Danhieux K, Buffel V, Pairon A, Benkheil A, Remmen R, Wouters E, et al. The impact of COVID-19 on chronic care according to providers: a qualitative study among primary care practices in Belgium. BMC Fam Pract. 2020;21(1):255.

Saqib MAN, Siddiqui S, Qasim M, Jamil MA, Rafique I, Awan UA, et al. Effect of COVID-19 lockdown on patients with chronic diseases. Diabetes Metab Syndr. 2020;14(6):1621–3.

Nair M, Ali MK, Ajay VS, Shivashankar R, Mohan V, Pradeepa R, et al. CARRS surveillance study: design and methods to assess burdens from multiple perspectives. BMC Public Health. 2012;12(1):701.

Mohan S, Jarhyan P, Ghosh S, Venkateshmurthy NS, Gupta R, Rana R, et al. UDAY: a comprehensive diabetes and hypertension prevention and management program in India. BMJ Open. 2018;8(6):e015919.

Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–43.

Toussaint A, Husing P, Gumz A, Wingenfeld K, Harter M, Schramm E, et al. Sensitivity to change and minimal clinically important difference of the 7-item generalized anxiety disorder questionnaire (GAD-7). J Affect Disord. 2020;265:395–401.

Fofana F, Bazeley P, Regnault A. Applying a mixed methods design to test saturation for qualitative data in health outcomes research. PLoS One. 2020;15(6):e0234898. h

Fisher MP, Hamer MK. Qualitative methods in health policy and systems research: a framework for study planning. Qual Health Res. 2020;30(12):1899–912.

Johnson SU, Ulvenes PG, Oktedalen T, Hoffart A. Psychometric properties of the general anxiety disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample. Front Psychol. 2019;10:1713.

Johnson GA, Vindrola-Padros C. Rapid qualitative research methods during complex health emergencies: a systematic review of the literature. Soc Sci Med. 2017;189:63–75.

Fagoonee I, Pellicano R. COVID-19 brings the world economy to its knees. Minerva Med. 2020;111(4):297–9.

Tiirinki H, Tynkkynen LK, Sovala M, Atkins S, Koivusalo M, Rautiainen P, et al. COVID-19 pandemic in Finland - preliminary analysis on health system response and economic consequences. Health Policy Technol. 2020;9(4):649–62

Downloads

Published

2023-12-31

How to Cite

1.
Awasthi A, Singh SK. Impact of COVID -19 on Healthy Life of People in India. Indian J Community Health [Internet]. 2023 Dec. 31 [cited 2024 Jul. 24];35(4):510-5. Available from: https://www.iapsmupuk.org/journal/index.php/IJCH/article/view/2711

Issue

Section

Original Article

Most read articles by the same author(s)

1 2 > >>